Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development

Poor aqueous solubility of drugs is still a foremost challenge in pharmaceutical product development. The use of lipids in designing formulations provides an opportunity to enhance the aqueous solubility and consequently bioavailability of drugs. Pre-dissolution of drugs in lipids, surfactants, or mixtures of lipid excipients and surfactants eliminate the dissolution/dissolving step, which is likely to be the rate-limiting factor for oral absorption of poorly water-soluble drugs. In this review, we exhaustively summarize the lipids excipients in relation to their classification, absorption mechanisms, and lipid-based product development. Methodologies utilized for the preparation of solid and semi-solid lipid formulations, applications, phase behaviour, and regulatory perspective of lipid excipients are discussed.

Lipid-based drug delivery systems (LBDDS) are formulations consisting of drugs dissolved or suspended in the lipid excipients. LBDDS have been extensively explored for delivering lipophilic drugs, wherein lipids maintain the drug in the solubilized form. LBDDS are usually formulated by the dissolution of the drug in the molten mixed lipids and emulsified with water to form a stable lipid system [3]. Solubility screening is most often performed for determining the best lipid excipients for a given drug. Surfactants are used to stabilize the lipid particles by reducing surface free energy or the interfacial energy of the solid particles, thus inhibiting aggregation. Lipid excipients also promote drug partitioning within the skin epidermal lipids and thus accelerate the penetration of drugs through and within human skin. Physicochemical properties and absorption mechanism of the lipids make them different from other classes of carriers leading to substantial cost saving and availability to reach the market.
In this review, we exhaustively cover the lipids excipients useful in formulation development with physicochemical and biochemical behaviour, along with the computational simulations in solubility prediction, phase behaviour, drug absorption and regulatory perspective. Lipid excipients are mainly categorized as triglycerides (TG), mixed glycerides and polar oils, water-soluble and insoluble surfactants, co-solvents, and other additives. Ethanol, propylene glycol, glycerol, and polyethylene glycols-400 (PEG-400) are the commonly used co-solvents along with lipid excipients. Surfactants of intermediate hydrophilic-lipophilic balance (HLB) (8–12 lipid excipients, water-insoluble surfactants) that shows adsorption at the oil-water interfaces are available commercially. The lipid-based synthetic surfactant (including non-ionic surfactants), e.g., PEG-40 Hydrogenated castor oil, PEG-60 Hydrogenated castor oil, Polyoxyl 35 hydrogenated castor oil, Polyoxyethylene (20) sorbitan monolaurate and Polyoxyethylene sorbitan monooleate, Glyceryl monooleate, Caprylocaproyl macrogol-8 glycerides, Oleoyl polyoxyl-6 glycerides, and Linoleoyl polyoxyl-6 glycerides are widely used lipid excipients. The water-insoluble surfactant (Propylene glycol monocaprylate, Propylene glycol monolaurate, and Polyglyceryl-3 dioleate) and water-soluble surfactant (Polyoxyl stearate, Polyoxyethylene lauryl ether) has been widely used in the lipid-based formulations.

Download the full article

Continue reading here

List of lipid excipients used in the pharmaceutical product development USFDA IID- United States of Food and drug administration inactive ingredient database, USP—United States Pharmacopeia, NF—National formulary.

Chemical NameFunctionalitiesExampleRegulatory Status
Caprylocaproyl macrogol-8 glyceridesSolubilizerSMEDDSFDA IID
Hard FatTaste masking, Hot melt coatingHME, Melt granulation, NLCsUSFDA
Glycerol dibehenateSustained-release, Lubricant, API protectionSR tablet, SLN and NLCsFDA IID
Glyceryl MonostearateLubricant, EmulsifierColloidal carriersUSFDA
Glycerol distearateSustained release,SR Tablet, Lipid nanoparticles, Hot melt coatingFDA IID
Lubricant, Taste-masking
Glyceryl MonocaprylatePermeability enhancer, Emulsifier, SolubilizerSEDDS, Nanoparticles [13]USP/NF
Propylene Glycol MonocaprylateEmulsifier, SolubilizerSEDDS, NanoparticlesUSFDA
Glycerol MonocaprylocaprateSolubilizer, penetration enhancerSNEDDSUSFDA
Succinic TriglyceridesSuper fattingCreamsUSFDA
Agent
Lauroyl macrogol-32 glyceridesBioavailability enhancerHard gelatin capsule (SNEDDS, SMEDDS), Mixed micellesFDA IID
Oleoyl macrogrol-32 glycerideBioavailability enhancer, SolubilizerOral solutions, SMEDDS FDA IID
Polyglyceryl-3 dioleateSurfactantNiosomesFDA IID
Propylene glycol dicaprylocaprateOily vehicleEmulsions and NanocapsulesFDA IID
TrimyristinControlled release, Lubricant, taste maskingSLNs [20], HME, SEDDS, SLMsUSFDA
Tristearin/Glyceryl TristearateControlled release, Lubricant, lipid carrierHME, Hot melt coating as a taste masking agent, SMEDDS and SLMsUSFDA
Glyceryl CaprylatePermeability enhancer, Emulsifier, SolubilizerSMEDDSIIG/USFDA
Polyoxyl stearateBioavailability enhancer(SNEDDS, SMEDDS) and Solid dispersion FDA IID
Stearoylmacrogol-32 glycerideBioavailability enhancerSolid dispersionFDA IID

 

Overview Lipd Excipients as of this article

TypeGroupExcipient
EmulsifierPolyoxethylene sorbitan fatty acid esterTween 20
EmulsifierPolyoxethylene sorbitan fatty acid esterTween 60
EmulsifierPolyoxethylene sorbitan fatty acid esterTween 80
EmulsifierPEGylated glyceridesLabrasol
EmulsifierPEGylated glyceridesGelucire 44/14
EmulsifierPEGylated glyceridesGelucire 50/13
EmulsifierPEGylated glyceridesAcconon MC8-2
EmulsifierPEGylated glyceridesAcconon C-44Acconon C-44
EmulsifierSorbitan fattyacid estersSpan 20
EmulsifierSorbitan fattyacid estersSpan 60
EmulsifierSorbitan fattyacid estersSpan 80
EmulsifierPolyethyleneglycold based derivatives of vitamin AD-alpha-Tocopherol PEG 10 succinate
EmulsifierPolyoxythelyne castor oil derivativesCremophor EL
EmulsifierPhospholipidsLecithin modified lecithin
Co-EmulsifiierPG monoester of medium-chain FACapmul PG-8
Co-EmulsifiierPG monoester of medium-chain FACapryol 90
Co-EmulsifiierPEGylated glyceridesLabrafil M1944
Co-EmulsifiierMonoglycerides of long-chain FAGlycerol monooleate
Co-EmulsifiierMonoglycerides of long-chain FAGlycerol monostearate
Co-EmulsifiierMonoglycerides of medium-chain FACapmul MCM
Co-EmulsifiierMono and diglycerides of medium chain FAImwitor 972
Co-EmulsifiierMono and diglycerides of medium chain FAImwitor 988
Co-EmulsifiierPoly-glyercol estersGlyeceryl tri-oleate Decaglycerol mono-oleate

About this article: Nakmode, D.; Bhavana, V.; Thakor, P.; Madan, J.; Singh, P.K.; Singh, S.B.; Rosenholm, J.M.; Bansal, K.K.; Mehra, N.K. Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development. Pharmaceutics 202214, 831. https://doi.org/10.3390/pharmaceutics14040831

You might also like